Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18734664

Rapamycin together with herceptin significantly increased anti-tumor efficacy compared to either alone in ErbB2 over expressing breast cancer cells

Author
WANG, Lu-Hai1 ; CHAN, Joseph L.-K1 ; WEI LI1
[1] Department of Microbiology, Mount Sinai School of Medicine, New York, NY, United States
Source

International journal of cancer. = Journal international du cancer. 2007, Vol 121, Num 1, pp 157-164, 8 p ; ref : 61 ref

CODEN
IJCNAW
ISSN
0020-7136
Scientific domain
Medical oncology
Publisher
Wiley-Liss, New York, NY
Publication country
United States
Document type
Article
Language
English
Author keyword
ErbB2 breast cancer herceptin rapamycin tumor growth
Keyword (fr)
Anticancéreux Anticorps monoclonal Association médicamenteuse Cancérologie Chimiothérapie Efficacité traitement Etude comparative Gène erbB2 Gène onc cellulaire Homme Immunothérapie Protooncogène Sirolimus Traitement associé Traitement Trastuzumab Anti-HER2 Cancer du sein Croissance tumorale Anticytokine Glande mammaire pathologie Génétique Inhibiteur synthèse protéique Lactone Macrocycle Macrolide Tumeur maligne
Keyword (en)
Antineoplastic agent Monoclonal antibody Drug combination Cancerology Chemotherapy Treatment efficiency Comparative study erbB2 Gene C-Onc gene Human Immunotherapy Protooncogene Sirolimus Combined treatment Treatment Trastuzumab Breast cancer Tumor growth Anticytokine Mammary gland diseases Genetics Protein synthesis inhibitor Lactone Macrocycle Macrolide Malignant tumor
Keyword (es)
Anticanceroso Anticuerpo monoclonal Asociación medicamentosa Cancerología Quimioterapia Eficacia tratamiento Estudio comparativo Gen erbB2 Gen onc celular Hombre Inmunoterapia Protooncogen Sirolimús Tratamiento asociado Tratamiento Trastuzumab Cáncer de pecho Anticitoquina Glándula mamaria patología Genética Inhibidor síntesis proteica Lactona Macrociclo Macrólido Tumor maligno
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R04 Combined treatments (chemotherapy of immunotherapy associated with an other treatment)

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B04 Tumors

Discipline
Pharmacological treatments Tumours
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
18734664

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web